Researchers unexpectedly found that the virus triggers a biochemical pathway, known as the immune complement system, in lung cells. That might explain why the disease is so difficult to treat. The research appears in the journal Science Immunology. The researchers propose that the pairing of antiviral drugs with drugs that inhibit this process may be more effective. Using an in vitro...